Trials / Unknown
UnknownNCT05519761
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Perouse Medical · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate performance and safety of POLYSITE® and SEESITE® implantable ports allowing repeated and prolonged access to the venous system for the administration of chemotherapy, antibiotics, antiviral drugs, parenteral nutrition, and for blood transfusion or blood derivatives transfusion.
Conditions
- Veinous
- Chemotherapy
- Antibiotics
- Antiviral Drugs
- Parenteral Nutrition
- Blood Transfusion
- Blood Derivatives Transfusion
- PMCF Study
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation of veinous access ports | The surgeon, anaesthetist and interventional radiologist should be thoroughly familiar with the surgical procedure, instruments, and device characteristics prior to performing the implantation. The nurse has also to be familiar with the implantable port since he/she intervenes in it at the time of the Huber needle puncture and solution injection. |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2022-10-30
- Completion
- 2022-10-30
- First posted
- 2022-08-29
- Last updated
- 2022-08-29
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05519761. Inclusion in this directory is not an endorsement.